CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 109 enrolled
Drug / intervention
Restylane Vitaldevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02545608
NCT02545608N/ACompleted

A Randomised, Multi-centre, Evaluator-blinded, Split-hand, no Treatment-controlled Study to Evaluate the Safety and Efficacy of Restylane Vital for Skin Rejuvenation of the Dorsal Hands in Chinese Subjects

Galderma R&D·interventional·Posted Sep 10, 2015·Updated Aug 26, 2022

In Brief

A clinical study evaluating Restylane Vital for Dorsal Hands. Completed, enrolled 109 participants across 2 sites.

Detailed Summary

The purpose of this study is to determine the safety and efficacy of using Restylane Vital for skin rejuvenation of the dorsal hands. Assessment of improvement of skin structure will be done by a blinded evaluator.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDorsal Hands
CountriesChina
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedSep 10, 2015
Enrollment StartOct 1, 2015
Primary CompletionApr 1, 2016
Study CompletionMar 15, 2017
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 10.8 years ago

Interventions

Restylane Vitaldevice